Skip to main content
. 2022 Sep 12;14(18):4427. doi: 10.3390/cancers14184427

Figure 1.

Figure 1

Overview of the strategy for identifying the best combinations of survival risk stratification markers using quantitative polymerase chain reaction (qPCR), liquid chromatography-mass spectrometry (LC-MS)/MS, and immunohistochemistry (IHC) using tissue microarrays (TMAs).